Antengene Announces XPOVIO Approval for Public Health Insurance in Taiwan
February 13, 2025
Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer, announced that XPOVIO (selinexor) in